Ginkgo Bioworks Holdings DNA
NYSE DNA
$9.98 +0.27 (+2.83%)
As of: Oct 23, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Return on Sales [ROS] (2020 - 2026)

Updated

Ginkgo Bioworks Holdings (DNA) posted Return on Sales [ROS] of -290.47% for Q2 2026, down 141.85 percentage points from -148.63% a year earlier but up 76.03 percentage points from the prior quarter.

Analysis

Ginkgo Bioworks Holdings (DNA) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Ginkgo Bioworks Holdings was -259.86%, down 118.16 percentage points year-over-year; for FY2025, it came in at -185.29%, up 61.25 percentage points from FY2024.

  • Annual Return on Sales [ROS] has increased for four consecutive years, though with a five-year change of -6.54 percentage points (FY2020 to FY2025).
  • In prior years, Ginkgo Bioworks Holdings' Return on Sales [ROS] was -246.54% in FY2024 (+97.22 pp), -343.76% in FY2023 (+118.65 pp), -462.41% in FY2022 (+120.21 pp) and -582.62% in FY2021 (-403.86 pp).
  • Quarterly Return on Sales [ROS] has run from a low of -1134.55% in Q4 2021 to a high of -34.37% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of +99.29 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2022, with a gain of 899.66 percentage points; the weakest was Q4 2021, with a drop of 960.21 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -366.51% (Q1 2026), -211.86% (Q4 2025) and -231.78% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Iqvia Holdings 46.32 Bn 38.02 Bn 1.44 Bn 11.58%
2 Medpace Holdings 18.64 Bn 16.29 Bn 223.89 Mn 23.12%
3 Charles River Laboratories International 16.55 Bn 15.75 Bn 363.37 Mn 11.94%
4 Icon 14.51 Bn 11.62 Bn 479.29 Mn 6.68%
5 Fortrea Holdings 2.23 Bn 1.61 Bn 139.20 Mn 2.18%
6 Ginkgo Bioworks Holdings 615.67 Mn -146.42 Mn 18.44 Mn -290.47%
7 Evotec SE 539.84 Mn -1.07 Bn - -
8 Champions Oncology 65.46 Mn 40.54 Mn 7.70 Mn -2.69%
9 MindWalk Holdings 53.84 Mn 17.49 Mn 1.61 Mn -159.86%
10 Natural Alternatives International 7.11 Mn -20.97 Mn 1.73 Mn -38.18%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -290.47%
Mar 31, 2026 -366.51%
Dec 31, 2025 -211.86%
Sep 30, 2025 -231.78%
Jun 30, 2025 -148.63%
Mar 31, 2025 -211.80%
Dec 31, 2024 -236.29%
Sep 30, 2024 -61.99%
Jun 30, 2024 -396.66%
Mar 31, 2024 -469.12%
Dec 31, 2023 -512.49%
Sep 30, 2023 -516.68%
Jun 30, 2023 -228.57%
Mar 31, 2023 -267.34%
Dec 31, 2022 -234.89%
Sep 30, 2022 -986.38%
Jun 30, 2022 -447.92%
Mar 31, 2022 -401.04%
Dec 31, 2021 -1,134.55%
Sep 30, 2021 -34.37%
API Access

Ginkgo Bioworks Holdings Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=DNA&period=max&api_key=YOUR_API_KEY